The groundbreaking approach of the medication represents a major development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment